Ovid Therapeutics Inc. is a New York-based biotech company using its BoldMedicine® approach to develop medicines that transform the lives of people affected by rare neurological disorders. Ovid seeks to couple deep CNS experience with emerging advances in genetics and the pathways of the brain to build a leading neuroscience pipeline. For more information, please visit www.ovidrx.com. Review our community guidelines: http://www.ovidrx.com/community-guidelines/